BioSig Technologies (NSDQ:BSGM) will work with the Mayo Foundation for Medical Education and Research to develop next-gen, AI-powered software for its Pure EP system, which is meant to take electrophysiology to the next level. The Mayo Clinic has already been an important investor and development partner for the Westport, Conn.–based company. BioSig signed a 10-year collaboration […]
BioSig Technologies
BioSig closes $17.5m offering
BioSig Technologies (NSDQ:BSGM) announced today that it closed a registered direct offering of common stock worth $17.5 million. The Westport, Conn.-based company and its majority-owned subsidiary, ViralClear Pharmaceuticals, sold nearly 2.2 million shares of common stock at $8 per share, closing the offering on June 26. Proceeds from the offering reached $17.5 million before deducting placement […]
BioSig Technologies announces 100th patient case with its ECG booster
BioSig Technologies (NSDQ:BSGM) announced today that it successfully completed 100 patient cases with its Pure EP electrocardiographic system. The Pure EP is designed to acquire, digitize, measure, display and store electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. Westport, Conn.–based BioSig initiated its first clinical trial in November 2019 and is currently enrolling at the Texas […]
BioSig signs licensing agreements with Mayo Clinic
BioSig Technologies (NSDQ:BSGM) announced today that it agreed to three new patent and know-how license agreements with the Mayo Foundation for Medical Education and Research. Under the agreements, BioSig plans to establish a new product pipeline for its Pure EP system for acquiring, digitizing, measuring, displaying and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology […]
BioSig opens new office in Rochester, Minn.
BioSig Technologies (NSDQ:BSGM) said yesterday that it is opening a technology development office in Rochester, Minn., in collaboration with Mayo Clinic. Westport, Conn.-based BioSig said its new office will serve as an R&D and product development hub in support of the projects developed through its strategic collaboration with Mayo Clinic and Mayo Ventures. Mayo Clinic, having […]
BioSig’s NeuroClear Technologies raises nearly $4m
BioSig Technologies (NSDQ:BSGM) said last week that its subsidiary, NeuroClear Technologies, raised nearly $4 million in an initial seed-funding round. NeuroClear said it intends to use the proceeds from the $3.7 million round to fund product development and initial pre-clinical studies, development of its intellectual property portfolio and for general corporate purposes. Founded in November 2018, […]
BioSig lands $1M investment from Mayo Clinic
Cardiac arrhythmia-detection startup BioSig Technologies (NSDQ:BSGM) has received nearly $1 million in financing from the Mayo Clinic after working with the healthcare organization for two years. BioSig recently completed first-in-human studies at the Rochester, Minn.-based clinic aimed at validating the safety and efficacy of its Pure EP system during mapping and ablation procedures in a cardiac EP lab. Patient […]
BioSig raises $9m
BioSig Technologies (OTCQB: BSGM) has raised $8.6 million in a new round of equity financing, according to a recently posed SEC filing. The Santa Monica, Calif.-based company is developing the Pure EP system, which is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. […]
BioSig inks Pure EP first-in-human study deal with Texas Cardiac Arrhythmia Institute
BioSig Technologies (OTCQB: BSGM) said today that it inked a deal with Austin’s Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to launch first-in-human studies using its Pure EP system. The Santa Monica, Calif.-based company’s Pure EP system is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals […]
BioSig to uplist to NASDAQ exchange
BioSig Technologies (OTCQB: BSGM) said this week it plans to uplist onto the Nasdaq Capital Market, beginning today. The Santa Monica, Calif.-based company said that the uplisting follows its receipt of FDA 510(k) clearance for its Pure EP electrophysiology system. BioSig said that the PureEP system is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, […]
BioSig raises $4m
BioSig Technologies (OTCQB: BSGM) has raised $4.1 million in a new round of equity and warrants financing, according to a recently posted SEC filing. The Santa Monica, Calif.-based company is looking for an additional $5.9 million before closing the round, aiming to raise a total of $10 million in the round. Funding in the round came from […]
